ASML's quarter, Intel's adoption, and the market's patience


ASML ASML is the better business to own if you want exposure to the equipment bottleneck, and Intel is the better name if you want to argue about whether the next wave of chip spending turns into actual product. That is the tension here. ASML has the quarter, the raised guide, and the capacity plan. Intel has the adoption story, but also the burden of execution that comes with it.
The market is not treating the semiconductor complex as a one-way trade. The Philadelphia Semiconductor Index has been swinging hard, including a drop of more than 4 percent on July 16 before a partial recovery, which tells you the tape is still asking for proof that AI spending can keep compounding into 2027 and beyond. Reuters also reported that some investors are positioning for slower hyperscaler spending growth, which is exactly the sort of doubt that can hit a capital equipment name even after a clean print. ASML's latest numbers land right in that argument.
ASML said second-quarter revenue reached €9.33 billion on July 15, and Reuters described the result as stronger than expected. The company then raised its full-year 2026 net sales outlook to €43 billion to €45 billion, up from the prior €36 billion to €40 billion band, and it said that move was driven by sustained demand for AI-related chips. That is the core of the story. The company is not talking about a one-off order spike. It is talking about a broader demand backdrop that still supports a higher full-year range after already moving the goalposts once this year.
Intel matters because it is one of the few names that gives the market a concrete customer-side read on ASML's High-NA EUV push. Yahoo Finance reported that Intel has begun using ASML's High-NA EUV tools for mass production of its Panther Lake processors on the 18A node. That is not a theoretical endorsement. It is a live production use case. For ASML, that matters more than a dozen generic comments about AI. It shows the toolset is moving from roadmap language into manufacturing reality.
The catch is that Intel is also the kind of customer that reminds you how long the payback cycle can be. A customer can adopt a tool and still spend years working through process ramps, yield issues, and node transitions. So while Intel's use of High-NA is a useful validation point, it is not a clean read on near-term revenue acceleration by itself. ASML's quarter is the cleaner evidence. Intel is the supporting cast.
ASML also said it plans to expand manufacturing capacity by 30 percent in 2027 and 2028. That is the sort of number management does not throw around casually. It tells you the company is preparing for a demand profile that it believes can absorb more output over a multi-year window. In a sector where the market has spent months debating whether AI capex is front-loaded or durable, a capacity expansion of that size is a more useful signal than another polished slide about secular growth.
The new readiness milestone for High-NA EUV matters for the same reason. ASML highlighted the first high-volume logic product, which is the kind of detail that separates a technology story from a marketing story. The company is not just selling future optionality. It is showing progress on the most advanced part of its lithography stack, and that stack remains the choke point for leading-edge logic manufacturing. If you want to know why ASML can raise guidance while the broader semiconductor index is still volatile, that is the answer.
This is also where the comparison with Intel sharpens. Intel is trying to prove that its own manufacturing roadmap can catch up. ASML is the supplier that sells the picks and shovels to everyone trying to do that. Intel's adoption of High-NA is useful because it confirms the tool's relevance. ASML's capacity plan is more important because it says the supplier sees enough demand to justify building more of the thing everyone needs.
No insider trading activity has been reported for ASML in the most recent three months, and the last recorded transactions occurred in February 2026, according to Insiderscreener. That leaves you with a company that has just improved its fundamentals and a stock that does not have a fresh insider footprint to help frame the move. In a name this large and this closely watched, that absence is not a verdict. It is just the fact pattern.
The comparison with Intel is useful here too. Intel is a more event-driven, more management-sensitive story, where insider behavior can sometimes matter more because the market is constantly reassessing execution risk. ASML is different. The business is more entrenched, the customer base is broader, and the order book dynamics are less dependent on one quarter of sentiment. So the lack of recent insider activity at ASML does not carry the same interpretive weight it might at a smaller, more levered name. Still, if you are looking for a fresh internal vote of confidence, it is not there.
That is where the insider record and the operating record diverge. The operating record is loud. The insider record is quiet. You should not force the quiet to mean something it does not. But you also should not pretend it adds conviction to the bullish case. It does not.

ASML's scale is the reason the market keeps paying attention every time it raises guidance. The company sits at the center of advanced lithography, and the July 15 update reinforced that position. Intel, by contrast, is still in the middle of proving that its own manufacturing ambitions can translate into consistent product and process execution. That makes Intel a useful peer for the story, but not a true substitute for ASML's business model.
The scale difference matters because the market is not just buying revenue. It is buying control points. ASML controls one of the most important ones in the semiconductor supply chain. Intel needs that control point. So do the foundries and logic customers that keep the AI buildout moving. When ASML says demand remains strong enough to lift 2026 sales guidance to €43 billion to €45 billion, it is speaking from a position of structural leverage that Intel does not have.
The broader sector backdrop makes that leverage more visible. Reuters noted that some investors are starting to question whether hyperscaler spending growth can stay as fast as it has been. That is exactly the kind of question that can compress multiples across the chip chain. But ASML is not a generic AI beneficiary. It is a toll collector on the leading edge. If spending slows, the market will still ask whether the next node transition needs its tools. Intel's High-NA use case says yes, at least for now.
There is no fresh insider cluster to read at ASML, so the insider angle is mostly about restraint. The last recorded transactions were in February 2026, and nothing has been reported in the most recent three months. That means the latest move in the stock is being driven by the company itself, not by a visible internal buying or selling pattern. For a reader trying to separate signal from noise, that is useful in its own way.
Our historical cohort data for this role-and-size bucket shows a T+90 return of -0.8 percent. That is historical cohort data, not a forecast for ASML, and it should be treated as a backdrop rather than a promise. The point is not that the number is negative and therefore ominous. The point is that this kind of insider bucket has not, on average, delivered a clean post-filing drift in the sample we track. In a case like ASML, where there is no fresh filing to anchor the read anyway, the operating update matters far more than any generic insider pattern would.
If you want the practical takeaway, it is simple. ASML's latest quarter and guidance raise are doing the heavy lifting. The insider record is inert. That is fine. Not every strong fundamental update needs an insider tailwind to be credible.
The semiconductor equipment group is still trading against a macro argument about AI capex durability. CNBC and Reuters both framed the wider debate around whether the current wave of spending can keep going at the same pace, and the market has been willing to punish any hint that the answer might be no. That is why ASML's July 15 update matters beyond the headline beat. It gives the bulls something concrete to point to when the index gets jumpy.
The company also gave them a second concrete point, the 30 percent capacity expansion in 2027 and 2028. That is not a sentiment slide. It is a capital and manufacturing commitment. If management were worried that demand was about to roll over, it would not be talking that way. The market can still argue about valuation, timing, and how much of the AI buildout is already in the price. It cannot easily argue that ASML is short on evidence.
Intel remains the useful foil because it reminds you where the risk sits. High-NA adoption is real, but customer execution is never frictionless. ASML can sell the tools and still be exposed to the pace at which customers turn them into volume output. That is the part of the story that keeps this from becoming a simple victory lap. The company is winning the technology race. The market still wants to know how fast the race turns into cash.
The next thing to watch is whether the raised 2026 range holds up as the year progresses. ASML has already lifted guidance twice this year, so the bar is higher now. If the company keeps translating AI-related demand into orders and shipments, the market will have to stop treating the stock as a proxy for abstract capex anxiety and start treating it as a business with visible demand and manufacturing leverage.
The second watchpoint is Intel's progress with High-NA EUV. If Intel keeps pushing the technology into mass production, that strengthens the case that ASML's most advanced tools are not just a future story. It also gives the market another customer-side data point to anchor the thesis. If Intel stumbles, the read gets messier, but it does not erase ASML's own quarter or the capacity plan.
The last thing to watch is the insider silence. If that changes, it will matter more than it does today because the company has just reset expectations upward. For now, though, the story is being written by revenue, guidance, and capacity, not by filings. ASML has given the market enough to argue about without needing an insider trade to fill the gap.
This is not investment advice.
Airbus trades near €195 as labor friction, engine bottlenecks and a new space JV frame the stock. The insider record sta...
Sanofi sits near recent lows after a strong Q2 and vaccine updates. The stock has no fresh insider buy to lean on, and t...
HSBC has a fresh buyback, a 23% profit jump and a stronger income guide. The catch is the stock already ran, and insider...
Vinci fell to 114.85 euros as July traffic softened, buybacks continued, and peers sold off. Here is what changed, and w...
AGCO’s latest SVP sale lands as farm equipment demand stays soft, peers trade stronger, and the insider cluster keeps gr...
Leonardo DRS trades near $37 while defense peers stay bid. Mark Dorfman sold EUR 237,930 under a 10b5-1 plan, after a wi...